IRINOTECAN for Neuroblastoma recurrent: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 74 adverse event reports in the FDA FAERS database where IRINOTECAN was used for Neuroblastoma recurrent.
Most Reported Side Effects for IRINOTECAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 4,157 | 14.9% | 558 | 1,893 |
| Neutropenia | 2,533 | 9.1% | 343 | 655 |
| Nausea | 2,374 | 8.5% | 228 | 1,029 |
| Disease progression | 2,018 | 7.2% | 628 | 271 |
| Off label use | 2,018 | 7.2% | 345 | 630 |
| Vomiting | 1,944 | 7.0% | 225 | 1,057 |
| Fatigue | 1,515 | 5.4% | 205 | 557 |
| Febrile neutropenia | 1,357 | 4.9% | 224 | 805 |
| Anaemia | 1,231 | 4.4% | 195 | 462 |
| Thrombocytopenia | 1,214 | 4.3% | 188 | 305 |
| Neuropathy peripheral | 1,207 | 4.3% | 75 | 183 |
| Asthenia | 1,154 | 4.1% | 157 | 557 |
| Pyrexia | 1,145 | 4.1% | 124 | 831 |
| Drug ineffective | 1,133 | 4.1% | 277 | 238 |
| Decreased appetite | 1,119 | 4.0% | 165 | 532 |
Other Indications for IRINOTECAN
Colorectal cancer metastatic (4,655)
Pancreatic carcinoma (2,128)
Colon cancer (2,105)
Product used for unknown indication (2,042)
Colorectal cancer (1,446)
Adenocarcinoma of colon (1,235)
Rectal cancer (985)
Pancreatic carcinoma metastatic (977)
Adenocarcinoma pancreas (908)
Colon cancer metastatic (841)
Other Drugs Used for Neuroblastoma recurrent
DINUTUXIMAB (102)
TEMOZOLOMIDE (84)
CYCLOPHOSPHAMIDE (77)
TOPOTECAN (56)
ETOPOSIDE (54)
CARBOPLATIN (39)
NAXITAMAB-GQGK (38)
IFOSFAMIDE (21)
LORLATINIB (21)
RITUXIMAB (21)